About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all events by:
- Date
- Subject
- Event Materials
- Title

Upcoming Events
Past Events
Event Series
Viewing AEI Webcasts
Listening to AEI Podcasts
Speeches
Government Testimony

E-NEWSLETTERS
Enter e-mail:
 

Home >  Events >  The Coming Age of the Über-Athlete: What's So Bad about Gene Enhancement and Doping?
The Coming Age of the Über-Athlete: What's So Bad about Gene Enhancement and Doping?
Print Mail
Start:  Thursday, December 18, 2008  9:00 AM
End:  Thursday, December 18, 2008  3:30 PM
Location:  Wohlstetter Conference Center, Twelfth Floor, AEI
1150 Seventeenth Street, N.W., Washington, D.C. 20036
Directions to AEI

It is said to be sports' doomsday scenario: a new generation of chemically enhanced or bioengineered athletes transformed from also-rans into world champions. We are entering an age often referred to as posthumanist, and sport is its leading edge. Elite athletes regularly remake their bodies in an effort to stretch human performance, benefiting from dramatic advances in medical technology, reconstructive surgery, and drug therapy. Most physiologists, ethicists, and sport authorities have attempted to draw a line--one that critics say is hazy and unenforceable--that makes certain performance-enhancing drugs and gene manipulation off limits. But the reaction to the Mitchell Report, the investigation commissioned by former senator George J. Mitchell into the use of steroids by Major League Baseball players, indicates that the public is less critical and far more ambivalent about how--or even whether--to control gene and drug enhancement.

Should gene manipulation and drugs be permitted to alter the mythical "level playing field" of life? Should humans be allowed or even encouraged to change their natural athletic endowments, and, if so, would that open the way for manipulating other innate characteristics? Considering that sports are heavily subsidized by governments and what occurs on the playing field is often a leading indicator for the exploitation of new technologies, what implications does this coming era of the über-athlete have for society and public policy?

8:45 a.m.
Registration
 
 
 
 
9:00 
Introduction: 

Jon Entine, AEI

 
 
 
9:10 
Opening Remarks: 
Travis Tygart, U.S. Anti-Doping Agency
 
 
 
10:00 
 
Panel I: Athletes under the Microscope
 
 
 
 
Panelists:
Dionne Koller, University of Baltimore School of Law
 
 
John Ruger, United States Olympic Committee
 
 
Kicker Vencill, elite swimmer
 
 
 
 
Moderator:  
Jon Entine, AEI
 
 
 
11:15 
 
Panel II: Drug Testing and Policy 
 
 
 
 
Panelists:
Theodore Friedman, University of California, San Diego
 
 
Paul Haagen, Duke University Center for Sports Law and Policy
 
 
 
Moderator:  
Randy Mayes, Triple Helix
 
 
 
12:30 p.m.
Luncheon
 
 
 
 
1:00  
Keynote Address:
Edwin Moses, Laureus World Sports Academy
 
 
 
2:00 
 
Panel III: Drugs, Genes, and the Future of Sports
 
 
 
 
Panelists:
Andy Miah, University of the West of Scotland
 
 
Thomas Murray, Hastings Center
 
 
 
 
Discussants: 
Theodore Friedman, University of California, San Diego
 
 
Paul Haagen, Duke University Center for Sports Law and Policy
 
 
 
 
Moderator:  
 
 
 
3:30 p.m. 
Adjournment
 

More Information
Jon Flugstad
American Enterprise Institute
 1150 Seventeenth Street, N.W.
Washington, DC  20036
Phone: 202-862-4878
E-mail: jon.flugstad@aei.org

Media Inquiries
Veronique Rodman
American Enterprise Institute
 1150 Seventeenth Street, N.W.
Washington, DC  20036
Phone: 202-862-4870
E-mail: VRodman@aei.org
AEI Print Index No. 23757


Event Materials
  Audio
  Video
Related Links
Speaker biographies